Tag Cloud Results

Results found matching tag Abbott

From the News
Abbott Named to the Dow Jones Sustainability Indexes for Seventh Consecutive Year in Recognition of Leading ...
Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb ...
Abbott Awards CFCareForward Scholarships to 40 Exceptional Graduate and Undergraduate Students Living ...
Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery
FDA Clears Abbott’s Genetic FISH Panel for Leukemia Patient Prognosis
First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical ...
Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate ...
Abbott’s PediaSure Brand Aims to Help Moms With Picky Eaters "Take Back the Table" By Building Lifelong ...
Abbott Introduces Vector-borne Pathogen Test to Detect Microorganisms Carried by Ticks and Other Insects
Abbott Receives U.S. FDA Approval for RX Herculink Elite Renal Stent System for Treatment of Renal Artery ...
Abbott Labs First in Foreign Trade Zone
Abbott’s HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further ...
Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development of New Formulations
Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune ...
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for ...
Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients with Chronic Kidney ...
Abbott Receives FDA Approval For CREON (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine ...
Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for Advanced ...
Abbott Statement on Interim Study Results of AIM-HIGH
Abbott Receives CE Mark for its RealTime Molecular Test for Cytomegalovirus
Abbott Receives U.S. FDA Approval for XIENCE nano to Treat Coronary Artery Disease in Small Vessels
Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection
Abbott Introduces New ZonePerfect Sweet & Salty Nutrition Bars
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
Abbott Statement on the FDA Advisory Committee Recommendations on Fenofibric Acid
Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay
Abbott's HUMIRA (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study
Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Receives CE Mark
Abbott Receives FDA Approval to Expand Use of the RX ACCULINK Carotid Stent System to Patients at Standard ...
Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone
Abbott Chairman and CEO Miles D. White Elected to the American Academy of Arts & Sciences
Data from Landmark Clinical Trial of Abbott's MitraClip System Demonstrate Durable Clinical Benefits
Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r ...
Abbott Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance ...
Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive Results
Abbott Introduces Hepatitis B Sequencing Test in Europe
Abbott Announces Launch of Catheter-Based MitraClip® System in Australia for Mitral Regurgitation
FDA Clears Abbott’s i-STAT 1 Wireless Point of Care Testing System
Abbott to Present Data on Novel Vascular Technologies and XIENCE V at ACC 2011
Abbott Introduces Micro-Implantation Cataract Suite
Abbott's new HIV-1 qualitative assay improves testing access in remote areas for children and adults
Abbott Supports Relief Efforts in Japan
Abbott to present at Barclays Capital 2011 global healthcare conference
Abbott Launches a CE Marked KIF6 Test in Europe
Abbott, Ranbaxy settle patent suit
Abbott Laboratories (NYSE:ABT) takes home award
Abbott - Offers rapid, accurate and broad detection of dangerous microorganisms